Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Е Н Семенкова
Observed names:
E N Semenkova,
E.N. Semenkova,
Eugenia N. Semenkova,
Е.Н. Семенкова
Institution:
Sechenov University
Observed institutions:
Sechenov University,
Russian Cancer Research Center NN Blokhin
OpenAlex ID:
A5111821347
Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
1997
·
E L Nassonov
, M Y Samsonov
, et al.
·
PubMed
·
38
Changing patterns of clinical severity and risk of mortality in granulomatosis with polyangiitis over four decades: the Russian experience
2014
·
Pavel I. Novikov
, Sergey V. Moiseev
, et al.
·
Rheumatology International
·
20
[Treatment of Wegener's granulomatosis with immunosuppressive agents].
1983
·
E N Semenkova
·
PubMed
·
11
[Involvement of lacrimal organs in Wegener's granulomatosis].
2009
·
T N Kiseleva
, Ia O Grusha
, et al.
·
PubMed
·
6
[Extrahepatic manifestations of chronic hepatitis C].
1998
·
T M Ignatova
, Z G Aprosina
, et al.
·
PubMed
·
6
Evaluation of the short-term efficacy and safety of biological agents in different rheumatic diseases: a multidisciplinary therapeutic hospital"s experience
2013
·
N A Mukhin
, P I Novikov
, et al.
·
Rheumatology Science and Practice
·
4
[Panniculitis in gout].
1992
·
G P Vorob'eva
, S Iu Generalova
, et al.
·
PubMed
·
4
[Myocarditis and fibroplastic endocarditis in Wegener's granulomatosis].
2010
·
L A Strizhakov
, D N Kogan
, et al.
·
PubMed
·
3
[Aortal regurgitation and atrioventricular block III in Wegener's granulomatosis].
2007
·
L A Strizhakov
, O G Krivosheev
, et al.
·
PubMed
·
3
[Treatment of periarteritis nodosa with immunosuppressants].
1985
·
E N Semenkova
, T N Lopatkina
·
PubMed
·
3
[Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases].
2013
·
S V Moiseev
, P I Novikov
, et al.
·
PubMed
·
2
Risk factors of atherosclerosis and clinical and morphological comparisons in systemic vasculitides
2012
·
Leonid Aleksandrovich Strizhakov
, S V Moiseyev
, et al.
·
Rheumatology Science and Practice
·
2
[The peculiarities of renal lesion in nodular polyarteritis].
2006
·
O V Klimenko
, E N Semenkova
, et al.
·
PubMed
·
2
[Cardiovascular complications and endothelial dysfunction in primary vasculitis].
2012
·
L A Strizhakov
, S V Moiseev
, et al.
·
PubMed
·
1
[Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment].
2011
·
P I Novikov
, O G Krivosheev
, et al.
·
PubMed
·
1
[Severe Wegener's granulomatosis successfully treated with rituximab].
2010
·
E N Semenkova
, O G Krivosheev
, et al.
·
PubMed
·
1
[Cardiac lesion in the Churg-Strauss syndrome].
2009
·
E A Kogan
, L A Strizhakov
, et al.
·
PubMed
·
1
[Use of interleukine-2 in a patient with renal cancer and paraneoplastic vasculitis].
2004
·
L V Demidov
, E N Semenkova
, et al.
·
PubMed
·
1
[Clinical aspects of hypereosinophilia syndrome].
2004
·
E N Semenkova
, S V Moiseev
, et al.
·
PubMed
·
1
[Abdominal emergencies in systemic vasculitis].
2002
·
O G Krivosheev
, E N Semenkova
, et al.
·
PubMed
·
1
[Immunological methods for assessing the activity of necrotizing vasculitis (Wegener's granulomatosis and microscopic polyarteritis) with kidney involvement].
1996
·
T V Beketova
, E L Nasonov
, et al.
·
PubMed
·
1
[Heart involvement in hypereosinophilia: the restrictive or the dilated type?].
1989
·
S V Moiseev
, E N Semenkova
, et al.
·
PubMed
·
1
[Course of bacterial infections in Wegener's granulomatosis patients].
1987
·
S V Griaznov
, E N Semenkova
, et al.
·
PubMed
·
1
Untitled
2014
·
L A Strizhakov
, S V Moiseev
, et al.
·
PubMed
Поражение сердца при системных васкулитах: патогенетические звенья, значение факторов риска развития сердечно-сосудистых осложнений и диагностика
2014
·
L A Strizhakov
, S V Moiseev
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Show more works
View as search
Works count:
67
Citation count:
114
H-index:
5
I10-index:
3
Year
Topic
Type